Advance the Development of TWO Antibiotics for USE in the Pediatric Population for the Treatment of Serious Bacterial Infections Where Multidrug-Resistant Organisms ARE Common, and 2) Develop Antibiotics for USE in Public Health and Biothreat Emergen
Contract Overview
Contract Amount: $47,521,248 ($47.5M)
Contractor: Melinta Therapeutics, LLC
Awarding Agency: Department of Health and Human Services
Start Date: 2023-07-06
End Date: 2030-06-30
Contract Duration: 2,551 days
Daily Burn Rate: $18.6K/day
Official Description: ADVANCE THE DEVELOPMENT OF TWO ANTIBIOTICS FOR USE IN THE PEDIATRIC POPULATION FOR THE TREATMENT OF SERIOUS BACTERIAL INFECTIONS WHERE MULTIDRUG-RESISTANT ORGANISMS ARE COMMON, AND 2) DEVELOP ANTIBIOTICS FOR USE IN PUBLIC HEALTH AND BIOTHREAT EMERGEN
Place of Performance
Location: District of Columbia, 20001